The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
Modes of action of Freund's adjuvants in experimental models of autoimmune diseases
Abstract
Freund's adjuvants are irreplaceable components of induction protocols of many experimental animal models of autoimmune disease. Apart from the early studies done in the 1950s and 1960s, no further direct investigation on the mode of action of these adjuvants has been undertaken. It is generally assumed that incomplete (IFA) and complete Freund's adjuvant (CFA) act by prolonging the lifetime of injected autoantigen, by stimulating its effective delivery to the immune system and by providing a complex set of signals to the innate compartment of the immune system, resulting in altered leukocyte proliferation and differentiation. Here, we review evidence collected from various types of studies that provide more insight in the specific alterations of the immune response caused by IFA and CFA. Early events include rapid uptake of adjuvant components by dendritic cells, enhanced phagocytosis, secretion of cytokines by mononuclear phagocytes, and transient activation and proliferation of CD4+ lymphocytes. The mycobacterial components within CFA signal T lymphocytes to assume a Th1 profile so that strong delayed-type hypersensitivity against autoantigens develops. In the absence of mycobacteria, T-lymphocyte differentiation tends to assume a Th2 profile with strong antibody production only. The mycobacterial component also accounts for a morphologic and functional remodeling of the haemopoietic system that develops over a period of several weeks and that is characterized by a drastic expansion of Mac-1+ immature myeloid cells. These cells have been found to be associated with enhanced disease in some models but with reduced disease in others. Thus, in experimental autoimmune diseases, CFA-mediated activation of the innate immune compartment is important not only by regulating the early induction phase but also by providing a surplus of effector and regulator cells in the late phase.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection.
Flynn, J. L., Chan, J., Triebold, K. J., Dalton, D. K., Stewart, T. A., & Bloom, B. R. (1993) · The Journal of experimental medicine · doi:10.1084/jem.178.6.2249 · Cited by 2,465
Ohashi, K., Burkart, V., Flohé, S., & Kolb, H. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.2.558 · Cited by 1,606
Autoimmunity to type II collagen an experimental model of arthritis.
Trentham, D. E., Townes, A. S., & Kang, A. H. (1977) · The Journal of experimental medicine · doi:10.1084/jem.146.3.857 · Cited by 1,603
Kindler, V., Sappino, A.-P., Grau, G. E., Piguet, P.-F., & Vassalli, P. (1989) · Cell · doi:10.1016/0092-8674(89)90676-4 · Cited by 1,254
T‐lymphocyte entry into the central nervous system
Hickey, W. F., Hsu, B. L., & Kimura, H. (1991) · Journal of Neuroscience Research · doi:10.1002/jnr.490280213 · Cited by 1,177
Immunisation against heterologous type II collagen induces arthritis in mice
Courtenay, J. S., Dallman, M. J., Dayan, A. D., Martin, A., & Mosedale, B. (1980) · Nature · doi:10.1038/283666a0 · Cited by 1,025
CpG Oligodeoxynucleotides Act as Adjuvants that Switch on T Helper 1 (Th1) Immunity
Chu, R. S., Targoni, O. S., Krieg, A. M., Lehmann, P. V., & Harding, C. V. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.10.1623 · Cited by 1,002
Development of Arthritis, Periarthritis and Periostitis in Rats Given Adjuvants.
Pearson, C. M. (1956) · Experimental Biology and Medicine · doi:10.3181/00379727-91-22179 · Cited by 842
Cooper, A. M., Magram, J., Ferrante, J., & Orme, I. M. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.1.39 · Cited by 715
OBSERVATIONS ON ATTEMPTS TO PRODUCE ACUTE DISSEMINATED ENCEPHALOMYELITIS IN MONKEYS
Rivers, T. M., Sprunt, D. H., & Berry, G. P. (1933) · Journal of Experimental Medicine · doi:10.1084/jem.58.1.39 · Cited by 643
Kol, A., Lichtman, A. H., Finberg, R. W., Libby, P., & Kurt-Jones, E. A. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.1.13 · Cited by 554
Sensing Pathogens and Tuning Immune Responses
Pulendran, B., Palucka, K., & Banchereau, J. (2001) · Science · doi:10.1126/science.1062060 · Cited by 461
Chu, C.-Q., Wittmer, S., & Dalton, D. K. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.1.123 · Cited by 418
Tsuji, S., Matsumoto, M., Takeuchi, O., Akira, S., Azuma, I., Hayashi, A., Toyoshima, K., & Seya, T. (2000) · Infection and Immunity · doi:10.1128/iai.68.12.6883-6890.2000 · Cited by 409
Hickey, W. F. (1991) · Brain Pathology · doi:10.1111/j.1750-3639.1991.tb00646.x · Cited by 357
Kamijo, R., Le, J., Shapiro, D., Havell, E. A., Huang, S., Aguet, M., Bosland, M., & Vilcek, J. (1993) · The Journal of experimental medicine · doi:10.1084/jem.178.4.1435 · Cited by 351
Chatterjee, D., & Khoo, K.-H. (1998) · Glycobiology · doi:10.1093/glycob/8.2.113 · Cited by 351
Flesch, I. E., Hess, J. H., Huang, S., Aguet, M., Rothe, J., Bluethmann, H., & Kaufmann, S. H. (1995) · The Journal of experimental medicine · doi:10.1084/jem.181.5.1615 · Cited by 345
Dalton, D. K., Haynes, L., Chu, C.-Q., Swain, S. L., & Wittmer, S. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.1.117 · Cited by 331
The role of interleukin-12 in acquired immunity to Mycobacterium tuberculosis infection.
Cooper, A. M., Roberts, A. D., Rhoades, E. R., Callahan, J. E., Getzy, D. M., & Orme, I. M. (1995) · PubMed Central · Cited by 308
Animal models, rheumatoid arthritis
(2011) · SpringerReference · doi:10.1007/springerreference_37459 · Cited by 296
Barnes, P. F., Chatterjee, D., Abrams, J. S., Lu, S., Wang, E., Yamamura, M., Brennan, P. J., & Modlin, R. L. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.149.2.541 · Cited by 294
Yip, H. C., Karulin, A. Y., Tary-Lehmann, M., Hesse, M. D., Radeke, H., Heeger, P. S., Trezza, R. P., Heinzel, F. P., Forsthuber, T., & Lehmann, P. V. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.7.3942 · Cited by 258
Ligands for natural killer cell receptors: redundancy or specificity
Cerwenka, A., & Lanier, L. L. (2001) · Immunological Reviews · doi:10.1034/j.1600-065x.2001.1810113.x · Cited by 248
Zhang, Y., Broser, M., Cohen, H., Bodkin, M., Law, K., Reibman, J., & Rom, W. N. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117702 · Cited by 234
Zhang, Y., Doerfler, M. E., Lee, T. C., Guillemin, B., & Rom, W. N. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116430 · Cited by 219
Roach, T. I., Barton, C. H., Chatterjee, D., & Blackwell, J. M. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.150.5.1886 · Cited by 215
Freund, J., Stern, E. R., & Pisani, T. M. (1947) · The Journal of Immunology · doi:10.4049/jimmunol.57.2.179 · Cited by 199
Macrophages are a significant source of type 1 cytokines during mycobacterial infection
Wang, J., Wakeham, J., Harkness, R., & Xing, Z. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6224 · Cited by 196
Lin, Y., Zhang, M., & Barnes, P. F. (1998) · Infection and Immunity · doi:10.1128/iai.66.3.1121-1126.1998 · Cited by 189
Zhang, Y., Broser, M., & Rom, W. N. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.6.2225 · Cited by 189
Dendritic Cells Internalize Vaccine Adjuvant after Intramuscular Injection
Dupuis, M., Murphy, T. J., Higgins, D., Ugozzoli, M., van Nest, G., Ott, G., & McDonald, D. M. (1998) · Cellular Immunology · doi:10.1006/cimm.1998.1283 · Cited by 185
Appelberg, R., Castro, A. G., Pedrosa, J., Silva, R. A., Orme, I. M., & Minóprio, P. (1994) · Infection and Immunity · doi:10.1128/iai.62.9.3962-3971.1994 · Cited by 182
Do heat shock proteins control the balance of T-cell regulation in inlammatory diseases?
van Eden, W., van der Zee, R., Paul, A. G. A., Prakken, B. J., Wendling, U., Anderton, S. M., & Wauben, M. H. M. (1998) · Immunology Today · doi:10.1016/s0167-5699(98)01283-3 · Cited by 166
The mode of action of mineral-oil emulsion adjuvants on antibody production in mice.
Herbert, W. J. (1968) · PubMed · Cited by 155
IL-6 produced by macrophages infected with Mycobacterium species suppresses T cell responses
Vanheyningen, T. K., Collins, H., & Russell, D. G. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.1.330 · Cited by 155
Immunostimulatory CpG-Oligodeoxynucleotides Cause Extramedullary Murine Hemopoiesis
Sparwasser, T. D., Hültner, L., Koch, E. S., Luz, A., Lipford, G. B., & Wagner, H. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.4.2368 · Cited by 147
Effectiveness of Lipid and Lipidophilic Substances as Adjuvants
Dresser, D. W. (1961) · Nature · doi:10.1038/1911169a0 · Cited by 146
Prevention of Insulitis and Diabetes Onset by Treatment With Complete Freund's Adjuvant in NOD Mice
McInerney, M. F., Pek, S., & Thomas, D. W. (1991) · Diabetes · doi:10.2337/diab.40.6.715 · Cited by 135
Wakeham, J., Wang, J., Magram, J., Croitoru, K., Harkness, R. E., Dunn, P., Zganiacz, A., & Xing, Z. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.12.6101 · Cited by 130
Chensue, S. W., Warmington, K. S., Ruth, J. H., Lukacs, N. W., & Kunkel, S. L. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.7.3565 · Cited by 125
Senaldi, G., Yin, S., Shaklee, C. L., Piguet, P. F., Mak, T. W., & Ulich, T. R. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.11.5022 · Cited by 122
Yamagami, H., Matsumoto, T., Fujiwara, N., Arakawa, T., Kaneda, K., Yano, I., & Kobayashi, K. (2001) · Infection and Immunity · doi:10.1128/iai.69.2.810-815.2001 · Cited by 110
Matthys, P., Vermeire, K., Mitera, T., Heremans, H., Huang, S., Schols, D., Wolf‐Peeters, C. D., & Billiau, A. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.6.3503 · Cited by 105
Self-citationThe immunobiology and clinical potential of immunostimulatory CpG oligodeoxynucleotides
Weiner, G. J. (2000) · Journal of Leukocyte Biology · doi:10.1189/jlb.68.4.455 · Cited by 104
Rabchevsky, A. G., Degos, J., & Dreyfus, P. A. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01479-1 · Cited by 102
Harshan, K. V., & Gangadharam, P. R. (1991) · Infection and Immunity · doi:10.1128/iai.59.8.2818-2821.1991 · Cited by 97
Matthys, P., Vermeire, K., Mitera, T., Heremans, H., Huang, S., Schols, D., Wolf-Peeters, C. D., & Billiau, A. (1999) · PubMed · Cited by 95
Self-citationHematopoietic Remodeling in Interferon-γ–Deficient Mice Infected With Mycobacteria
Murray, P. J., Young, R. A., & Daley, G. Q. (1998) · Blood · doi:10.1182/blood.v91.8.2914.2914_2914_2924 · Cited by 80
Revisiting Tolerance Induced by Autoantigen in Incomplete Freund’s Adjuvant
Heeger, P. S., Forsthuber, T. G., Shive, C. L., Biekert, E. J., Genain, C. P., Hofstetter, H. H., Karulin, A. Y., & Lehmann, P. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.11.5771 · Cited by 80
Animal models of rheumatoid arthritis
Joe, B., & Wilder, R. L. (1999) · Molecular Medicine Today · doi:10.1016/s1357-4310(99)01528-2 · Cited by 74
Castro, A. G., Silva, R. A., & Appelberg, R. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.4.2013 · Cited by 62
MÜSSENER, Å., Klareskog, L., Lorentzen, J. C., & Kleinau, S. (1995) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.1995.tb03635.x · Cited by 58
Matthys, P., Vermeire, K., & Billiau, A. (2001) · Trends in Immunology · doi:10.1016/s1471-4906(01)01937-8 · Cited by 52
Self-citationBone Marrow Changes in Adjuvant‐Induced and Collagen‐Induced Arthritis
Hayashida, K., Ochi, T., Fujimoto, M., et al. (1992) · Arthritis & Rheumatism · doi:10.1002/art.1780350219 · Cited by 50
Sancéau, J., FALCOFF, R., Béranger, F., Carter, D. B., & Wietzerbin, J. (1990) · PubMed Central · Cited by 47
Possible mechanism of the preventive effect of BCG against diabetes mellitus in NOD mouse
Yagi, H., Matsumoto, M., Suzuki, S., Misaki, R., Suzuki, R., Harada, M., & Making, S. (1991) · Cellular Immunology · doi:10.1016/0008-8749(91)90138-2 · Cited by 44
Matthys, P., Vermeire, K., Heremans, H., et al. (2000) · PubMed · Cited by 42
Self-citationToder, V., Strassburger, D., Irlin, Y., CARP, H. J. A., Pecht, M., & Trainin, N. (1990) · American Journal of Reproductive Immunology · doi:10.1111/j.1600-0897.1990.tb01040.x · Cited by 42
Extolling the diversity of bacterial endotoxins
Golenbock, D. T., & Fenton, M. J. (2001) · Nature Immunology · doi:10.1038/86289 · Cited by 38
杉崎, 勝., Dannenberg, A. M., Abe, Y., Tsuruta, J., Su, W., Said, W., Feng, L., Yoshimura, T., Converse, P. J., & Mounts, P. (1998) · Journal of Leukocyte Biology · doi:10.1002/jlb.63.4.440 · Cited by 37
Matthys, P., Vermeire, K., Heremans, H., et al. (2000) · Journal of Leukocyte Biology · doi:10.1189/jlb.68.4.447 · Cited by 37
Self-citationZhang, Mia, M., Zheng, Z., Hossain, Yamasaki, Tokunaga, & Kohashi (1999) · Immunology · doi:10.1046/j.1365-2567.1999.00854.x · Cited by 33
Cited by
Direct recognition of the mycobacterial glycolipid, trehalose dimycolate, by C-type lectin Mincle
Ishikawa, E., Ishikawa, T., Morita, Y. S., Toyonaga, K., Yamada, H., Takeuchi, O., Kinoshita, T., Akira, S., Yoshikai, Y., & Yamasaki, S. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20091750 · Cited by 792
Pattern recognition receptors and control of adaptive immunity
Palm, N. W., & Medzhitov, R. (2009) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00731.x · Cited by 729
Fujii, S.-I., Shimizu, K., Smith, C., Bonifaz, L., & Steinman, R. M. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030324 · Cited by 711
Multiple sclerosis: experimental models and reality
Lassmann, H., & Bradl, M. (2017) · Acta Neuropathologica · doi:10.1007/s00401-016-1631-4 · Cited by 525
GlaxoSmithKline Adjuvant Systems in vaccines: concepts, achievements and perspectives
Garçon, N., Chomez, P., & Van Mechelen, M. (2007) · Expert Review of Vaccines · doi:10.1586/14760584.6.5.723 · Cited by 476
Metadata
- Authors
- Billiau, A., & Matthys, P.
- Venue
- Journal of Leukocyte Biology
- Publisher
- Oxford University Press (OUP)
- Published
- 2001-12-01
- Volume
- 70
- Issue
- 6
- Pages
- 849-860
- ISSN
- 0741-5400 (ISSN-L)
- 1938-3673
- OpenAlex
- W2106781193
- Cited by
- 617
- References
- 63
- FWCI
- 3.21
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.